Indian regulators order Sun Pharma to halt eye-care drug production at Assam plant
Indian drug regulators have ordered Sun Pharmaceutical Industries (SUNPHARMA) to stop manufacturing, selling and distributing ophthalmic products made at its Assam facility after finding failures in its quality management system.
